• 提示：詳情請(qǐng)下載說明書。

• 產(chǎn)品描述： IC-87114 is a potent and selective PI3Kδ inhibitor with IC50 of 0.5 μM.

• 靶點(diǎn)： PI3Kδ:0.5 μM (IC50);PI3Kγ:29 μM (IC50);PI3Kβ:75 μM (IC50);PI3K

• 體內(nèi)研究：
  Treatment with PD 89059 (10?mg/kg), IC-87114 (0.3?mg/kg) and BAY 11-7085 (10?mg/kg), significantly (P<0.05) reduces the OVA- induced inflammatory cell influx into the airways and the histopathological airway remodeling. However, these treatments does not significantly improve OVA induced-AHR (P>0.05). Of note, the observed reduction in the histopathological airway remodeling induced by PD 89059, IC-87114 and BAY 11-7085 are less effective as compared to the reduction seen with AG 1478 and SU6656

• 參考文獻(xiàn)：
  1. Sadhu C, et al. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol. 2003 Mar 1;170(5):2647-54. 2. Zheng L, et al. Inactivation of PI3Kδ induces vascular injury and promotes aneurysm development by upregulating the AP-1/MMP-12 pathway in macrophages. Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):368-77. 3. El-Hashim AZ, et al. Src-dependent EGFR transactivation regulates lung inflammation via downstream signaling involving ERK1/2, PI3Kδ/Akt and NFκB induction in a murine asthma model. Sci Rep. 2017 Aug 30;7(1):9919.

• 溶解性： Soluble  in  DMSO

• 保存條件： -20℃

• 配置溶液濃度參考：
  

  	1mg	5mg	10mg
  1 mM	2.516 ml	12.581 ml	25.162 ml
  5 mM	0.503 ml	2.516 ml	5.032 ml
  10 mM	0.252 ml	1.258 ml	2.516 ml
  50 mM	0.05 ml	0.252 ml	0.503 ml

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

輸入產(chǎn)品批號(hào)：

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *